Urinary Tract Infections Caused by ESBL-producing Enterobacteria
NCT03501901 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 353
Last updated 2018-04-19
Summary
The aim of this study was to compare the etiologic agents, the antimicrobial resistance rates, and the risk factors associated with a HA-UTI and CA-UTI among complicated and uncomplicated UTI patients in a tertiary-care hospital in Mexico. This study was performed according to the principles expressed in the Declaration of Helsinki with the approval of the Local Ethics Committee of the School of Medicine of the Universidad Autónoma de Nuevo León (UR14-004). All patients with a UTI and a positive urine culture (\> 100,000 UFC/mL) from March to October 2015 were included. The study was carried out at the Hospital Universitario "Dr. José Eleuterio González" hospital, a tertiary-care teaching hospital in Monterrey, Mexico. Identification and susceptibility antibiotic assays were performed to all isolates from positive urine culture.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Antibiotic susceptibility test
Sponsors & Collaborators
-
Hospital Universitario Dr. Jose E. Gonzalez
collaborator OTHER -
Universidad Autonoma de Nuevo Leon
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-01
- Primary Completion
- 2015-10-31
- Completion
- 2017-10-01
More Related Trials
-
Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria
NCT03338738 ·Status: COMPLETED ·Phase: NA
-
Selective Reporting for Antibiotic Susceptibility Testing and GPs' Prescribing of Broad-spectrum Antibiotics in Women With E. Coli UTIs
NCT06067386 ·Status: UNKNOWN ·Phase: NA
-
Resistance Profile of Escherichia Coli in Infections of Community Origin: The Importance of Antimicrobial Stewardship
NCT06305455 ·Status: NOT_YET_RECRUITING
-
Does the National Health Insurance Card Allow us to Predict Antibiotic Resistance?
NCT02292160 ·Status: COMPLETED
-
Prognostic Factors of Escherichia Coli Bloodstream Infections: Severity Score and Therapeutic Implications
NCT02890901 ·Status: COMPLETED
-
Extended Spectrum Betalactamase Producing Bacteria; Epidemiology and Treatment in Non-hospitalized Patients
NCT01838213 ·Status: COMPLETED
-
Community Antibiotic Use, Susceptibility and ResisTance Among Patients With Urinary Tract Infections (CAST-UTI)
NCT07012421 ·Status: RECRUITING
-
Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli
NCT00573235 ·Status: COMPLETED
-
Prognostic Factors and Therapeutic Management of ESBL Enterobacteriaceae in the ICU
NCT05833282 ·Status: UNKNOWN
-
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
NCT01345929 ·Status: COMPLETED ·Phase: PHASE3
-
Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection
NCT04131569 ·Status: UNKNOWN
-
Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia
NCT06833593 ·Status: RECRUITING
-
Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.
NCT02852902 ·Status: COMPLETED
-
Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study
NCT01764490 ·Status: COMPLETED
-
The Prevalence of Extend-Spectrum β-Lactamase (ESBL) Producing Isolates Among Common Enterobacteriaceae in Taiwan
NCT01725841 ·Status: COMPLETED
-
Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli
NCT01820793 ·Status: TERMINATED ·Phase: NA
-
Treatment of Extended Spectrum Betalactamase Producing Bacteria Causing Urinary Tract Infections in General Practice
NCT01531023 ·Status: COMPLETED
-
Infections Caused by ESbL-Producing Enterobacteriaceae in Italy
NCT00404625 ·Status: UNKNOWN
-
Antimicrobial Resistance Rate In Escherichia Coli And Klebsiella Pneumonia : A Retrospective Study
NCT04196387 ·Status: COMPLETED
-
Antibiotic Resistant Community-Acquired E. Coli
NCT00298103 ·Status: COMPLETED
-
Fecal ESBL Resurgence During Antibiotic Treatment
NCT03206879 ·Status: TERMINATED
-
Dynamics of the Urinary Bacterial Microbiota
NCT07020676 ·Status: COMPLETED
-
Research of the Consequences on the Digestive Tract Following the Proposed Treatments for a Urinary Infection in Children
NCT03825874 ·Status: RECRUITING
-
Can the Relative Fecal Abundance of BLSE and the Digestive Microbiota be Predictive of the Risk of Infection in a Carrier Patient?
NCT04699981 ·Status: UNKNOWN ·Phase: NA
-
Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae
NCT04903886 ·Status: UNKNOWN